Logo image of VXZ

IPATH SER B S&P 500 VIX M/T (VXZ) Stock Overview

USA - NYSEARCA:VXZ - US06748M1889 - ETF

55.5166 USD
-0.13 (-0.24%)
Last: 10/3/2025, 8:11:44 PM
Fundamental Rating

2

VXZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 392 industry peers in the Banks industry. Both the profitability and financial health of VXZ have multiple concerns. While showing a medium growth rate, VXZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year VXZ was profitable.
In the past year VXZ has reported a negative cash flow from operations.
Each year in the past 5 years VXZ has been profitable.
Of the past 5 years VXZ 4 years had a positive operating cash flow.
VXZ Yearly Net Income VS EBIT VS OCF VS FCFVXZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.33%, VXZ is doing worse than 82.40% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.00%, VXZ is doing worse than 63.27% of the companies in the same industry.
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
VXZ Yearly ROA, ROE, ROICVXZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

VXZ's Profit Margin of 17.31% is on the low side compared to the rest of the industry. VXZ is outperformed by 70.15% of its industry peers.
VXZ's Profit Margin has improved in the last couple of years.
VXZ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 17.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXZ Yearly Profit, Operating, Gross MarginsVXZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

VXZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VXZ has been reduced compared to 1 year ago.
Compared to 5 years ago, VXZ has less shares outstanding
Compared to 1 year ago, VXZ has about the same debt to assets ratio.
VXZ Yearly Shares OutstandingVXZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXZ Yearly Total Debt VS Total AssetsVXZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

VXZ has a Debt/Equity ratio of 3.86. This is a high value indicating a heavy dependency on external financing.
VXZ has a worse Debt to Equity ratio (3.86) than 94.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.32%
VXZ Yearly LT Debt VS Equity VS FCFVXZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXZ Yearly Current Assets VS Current LiabilitesVXZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

4

3. Growth

3.1 Past

VXZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.12%, which is quite impressive.
The Earnings Per Share has been growing by 11.00% on average over the past years. This is quite good.
Looking at the last year, VXZ shows a small growth in Revenue. The Revenue has grown by 5.48% in the last year.
VXZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.03% yearly.
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%

3.2 Future

Based on estimates for the next years, VXZ will show a small growth in Earnings Per Share. The EPS will grow by 7.97% on average per year.
The Revenue is expected to grow by 3.56% on average over the next years.
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y7.97%
Revenue Next Year8.53%
Revenue Next 2Y6.59%
Revenue Next 3Y5.54%
Revenue Next 5Y3.56%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VXZ Yearly Revenue VS EstimatesVXZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXZ Yearly EPS VS EstimatesVXZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.60, VXZ is valued on the expensive side.
82.40% of the companies in the same industry are cheaper than VXZ, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.86, VXZ is valued a bit cheaper.
VXZ is valuated rather expensively with a Price/Forward Earnings ratio of 18.92.
VXZ's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. VXZ is more expensive than 78.57% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. VXZ is around the same levels.
Industry RankSector Rank
PE 21.6
Fwd PE 18.92
VXZ Price Earnings VS Forward Price EarningsVXZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXZ Per share dataVXZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VXZ does not grow enough to justify the current Price/Earnings ratio.
VXZ's earnings are expected to grow with 14.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.46
PEG (5Y)1.96
EPS Next 2Y15.3%
EPS Next 3Y14.66%

3

5. Dividend

5.1 Amount

VXZ has a Yearly Dividend Yield of 2.24%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.52, VXZ is paying slightly less dividend.
VXZ's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.24%

5.2 History

The dividend of VXZ is nicely growing with an annual growth rate of 6.61%!
VXZ is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The dividend of VXZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y15.3%
EPS Next 3Y14.66%
VXZ Yearly Income VS Free CF VS DividendVXZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

IPATH SER B S&P 500 VIX M/T

NYSEARCA:VXZ (10/3/2025, 8:11:44 PM)

55.5166

-0.13 (-0.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners55.08%
Inst Owner Change15.51%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap193.94B
Analysts79.09
Price Target61.26 (10.35%)
Short Float %0%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 2.24%
Yearly Dividend0.87
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.13%
PT rev (3m)-11.92%
EPS NQ rev (1m)0.34%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-0.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.04%
Valuation
Industry RankSector Rank
PE 21.6
Fwd PE 18.92
P/S 4.71
P/FCF N/A
P/OCF N/A
P/B 1.91
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)2.57
EY4.63%
EPS(NY)2.93
Fwd EY5.29%
FCF(TTM)-3.9
FCFYN/A
OCF(TTM)-3.9
OCFYN/A
SpS11.78
BVpS29.13
TBVpS25.99
PEG (NY)2.46
PEG (5Y)1.96
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.31%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y7.97%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%
Revenue Next Year8.53%
Revenue Next 2Y6.59%
Revenue Next 3Y5.54%
Revenue Next 5Y3.56%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A